Genitourinary cancers are comprised of physiologically complex and challenging-to-treat tumor types. In recent years, clinical and basic science research has resulted in many major advances in understanding the pathophysiology and management strategies of these diseases. In addition to the approval by the FDA of new pharmacological agents, the newly-gleaned insights and changing treatment strategies have led to the revision of current diagnosis and...